Capital Square, LLC Bristol Myers Squibb CO Transaction History

Capital Square, LLC

$162 Million
Q3 2024

A detailed history of Capital Square, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Square, LLC holds 5,842 shares of BMY stock, worth $340,179. This represents 0.19% of its overall portfolio holdings.

Number of Shares

5,842

Previous 5,793 0.85%

Holding current value

$340,179

Previous $240,000 25.83%

% of portfolio

0.19%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $1,943 - $2,535	49 Added 0.85%	5,842 $302,000
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $18,595 - $24,481	-462 Reduced 7.39%	5,793 $240,000
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $3,790 - $4,297	79 Added 1.28%	6,255 $339,000
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $6,496 - $7,751	-134 Reduced 2.12%	6,176 $316,000
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $5,325 - $5,955	92 Added 1.48%	6,310 $366,000
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $2,803 - $3,112	44 Added 0.71%	6,218 $397,000
Q1 2023 Apr 24, 2023	BUY	$65.71 - $74.53 $18,004 - $20,421	274 Added 4.64%	6,174 $427,000
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $9,450 - $11,190	-138 Reduced 2.29%	5,900 $424,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $27 - $16,290	212 Added 3.64%	6,038 $429,000
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $12,781 - $14,076	-176 Reduced 2.93%	5,826 $448,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $8,484 - $10,173	-138 Reduced 2.25%	6,002 $438,000
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $2,627 - $3,063	49 Added 0.8%	6,140 $381,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $43,489 - $50,942	735 Added 13.72%	6,091 $362,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $6,562 - $7,146	106 Added 2.02%	5,356 $359,000
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $69,249 - $77,885	1,167 Added 28.58%	5,250 $328,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $26,156 - $29,639	-453 Reduced 9.99%	4,083 $253,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $57 - $63	-1 Reduced 0.02%	4,536 $273,000
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $2,584 - $2,863	-45 Reduced 0.98%	4,537 $273,000
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $5,262 - $6,152	-96 Reduced 2.05%	4,582 $269,000
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $3,665 - $5,326	79 Added 1.72%	4,678 $261,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $226,316 - $295,209	4,599 New	4,599 $295,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Square, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Square, LLC with notifications on news.

Account

Capital Square, LLC Bristol Myers Squibb CO Transaction History